Evidence map›Paper›PMID 26063214›Full record

SynthesisChinese journal of cancer2015

TLR3 gene polymorphisms in cancer: a systematic review and meta-analysis.

Ben-Gang Wang, De-Hui Yi, Yong-Feng Liu

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Chinese journal of cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Analyses of haplotypes ofFrontiers in genetics · 2025
    Article
  4. Article
  5. Article
  6. Analysis of associations between theFrontiers in cellular and infection microbiology · 2023
    Article
  7. Review
  8. ERVs-TLR3-IRF axis is linked to myelodysplastic syndrome pathogenesis.Medical oncology (Northwood, London, England) · 2021
    Article
  9. Review
  10. Article
  11. Experimental hematology & oncology · 2019
    Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ben-Gang WangDepartment 1 of General Surgery, the First Affiliated Hospital of China Medical University, Shenyang, Liaoning, 110001, Peoples Republic of China. wangbengang2008@163.com.
De-Hui YiDepartment 1 of General Surgery, the First Affiliated Hospital of China Medical University, Shenyang, Liaoning, 110001, Peoples Republic of China. ydh1900@sina.com.
Yong-Feng LiuDepartment 1 of General Surgery, the First Affiliated Hospital of China Medical University, Shenyang, Liaoning, 110001, Peoples Republic of China. liuyongfengsubmit@163.com.
China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRecent studies examining the association of Toll-like receptor 3 (TLR3) gene polymorphisms with the risk of developing various types of cancer have reported conflicting results. Clarifying this association could advance our knowledge of the influence of TLR3 single nucleotide polymorphisms (SNPs) on cancer risk.

methodsWe systematically reviewed studies that focused on a collection of 12 SNPs located in the TLR3 gene and the details by which these SNPs influenced cancer risk. Additionally, 14 case-control studies comprising a total of 7997 cases of cancer and 8699 controls were included in a meta-analysis of 4 highly studied SNPs (rs3775290, rs3775291, rs3775292, and rs5743312).

resultsThe variant TLR3 genotype rs5743312 (C9948T, intron 3, C>T) was significantly associated with an increased cancer risk as compared with the wild-type allele (odds ratio [OR]=1.11, 95% confidence interval [CI]=1.00-1.24, P=0.047). No such association was observed with other TLR3 SNPs. In the stratified analysis, the rs3775290 (C13766T, C>T) variant genotype was found to be significantly associated with an increased cancer risk in Asian populations. Additionally, the rs3775291 (G13909A, G>A) variant genotype was significantly associated with an increased cancer risk in Asians, subgroup with hospital-based controls, and subgroup with a small sample size.

conclusionAfter data integration, our findings suggest that the TLR3 rs5743312 polymorphism may contribute to an increased cancer risk.

Indexed as

NeoplasmsPolymorphism, Single NucleotideToll-Like Receptor 3AllelesAsian PeopleCase-Control StudiesGenetic Predisposition to DiseaseGenotypeHumansIntronsOdds RatioPolymorphism, GeneticRiskTLR3 protein, humanToll-Like Receptor 3

Identifiers

PMID26063214
PMCPMC4593388
OpenAlexW1792405584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.